marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2023-Q3
added 11-06-2023
Aridis Pharmaceuticals Financial Ratios 2011-2024 | ARDS
Annual Financial Ratios Aridis Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.1 | -0.5 | -780.0 | -2.0 | -1.3 | - | - | - | - | - | - | - |
P/S |
1.3 | 14.5 | 17419.7 | 58.7 | 10.4 | - | - | - | - | - | - | - |
EPS |
-1.6 | -3.8 | -2.4 | -3.5 | -7.5 | -165.0 | - | - | - | - | - | - |
EV (Enterprise Value) |
38.2 M | 44.1 M | 33 M | 63.4 M | 9.85 M | -10.1 M | 8.76 M | - | - | - | - | - |
EBITDA per Share |
-1.57 | -3.44 | -0.00889 | -3.4 | -7.57 | - | - | - | - | - | - | - |
EV/EBITDA |
-0.8 | -416.4 | -1.4 | -0.2 | - | - | - | - | - | - | - | |
PEG |
- | -7.82 | -0.04 | 0.01 | - | - | - | - | - | - | - | |
P/B |
-0.2 | -1.7 | -2.0 | 16.5 | 1.1 | - | - | - | - | - | - | - |
P/CF |
-0.1 | -1.0 | -0.8 | -7.2 | -1.2 | - | - | - | - | - | - | - |
ROE % |
125.33 | 321.84 | 0.26 | -816.31 | -84.00 | - | - | - | - | - | - | - |
ROA % |
-206.68 | -157.46 | -0.15 | -106.13 | -69.93 | - | - | - | - | - | - | - |
ROCE % |
123.77 | 325.79 | 0.31 | -336.81 | -91.65 | - | - | - | - | - | - | - |
Current Ratio |
0.4 | 0.7 | 0.6 | 1.3 | 5.4 | - | - | - | - | - | - | - |
DSO |
59.0 | - | - | 696.4 | 219.8 | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
59.0 | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
59.0 | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Aridis Pharmaceuticals
| 2023-Q3 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
- | - | -0.47 | -0.45 | -0.44 | - | -1.94 | -0.49 | -0.77 | - | -0.65 | -0.47 | -0.73 | - | -0.87 | -1.03 | -0.99 | - | -1.97 | -11.78 | -48.99 | - | -37.3 | -40.77 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.02 | - | -0.41 | -0.42 | -0.41 | - | -1.67 | -0.54 | -0.67 | - | -0.62 | -0.46 | -0.73 | - | -0.82 | -1 | -0.94 | - | -1.6 | -26.6 | -44 | - | -32.8 | -23.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
75.27 | 89.62 | 595.08 | 1077.54 | 1089.68 | 626.72 | 693.37 | 254.56 | 262.46 | 190.19 | -18.48 | -293.79 | -572.96 | -660.97 | -691.03 | -512.42 | -287.28 | -63.34 | -54.71 | -16.02 | -0.92 | 18.32 | 18.32 | 9.69 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-185.05 | -148.40 | -228.92 | -241.45 | -241.85 | -167.95 | -206.22 | -163.98 | -143.69 | -109.21 | -136.34 | -125.20 | -127.26 | -85.93 | -110.95 | -108.84 | -83.37 | -52.73 | -73.19 | -68.63 | -87.10 | -43.44 | -43.44 | -22.97 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
76.44 | 84.77 | 590.81 | 1076.16 | 1094.68 | 632.91 | 699.63 | 260.31 | 262.81 | 190.97 | -12.41 | -282.52 | -558.58 | -643.51 | -668.67 | -490.44 | -280.40 | -70.46 | -61.72 | -27.82 | -4.19 | 15.08 | 15.08 | 6.34 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
0.4 | 0.4 | 0.2 | 0.4 | 0.5 | 0.7 | 0.9 | 0.5 | 0.7 | 0.6 | 0.6 | 0.6 | 0.6 | 1.1 | 1.1 | 1.1 | 1.1 | 6.0 | 6.0 | 6.0 | 6.0 | 1.8 | 1.8 | 1.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
155.0 | - | 114.3 | 156.2 | - | - | 88.6 | - | - | - | - | - | - | - | - | - | 74.1 | - | 148.2 | 6885.2 | 235.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
155.0 | - | 114.3 | 156.2 | - | - | 88.6 | - | - | - | - | - | - | - | - | - | 74.1 | - | 148.2 | 6885.2 | 235.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
155.0 | - | 114.3 | 156.2 | - | - | 88.6 | - | - | - | - | - | - | - | - | - | 74.1 | - | 148.2 | 6885.2 | 235.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency